This company seems to have been delisted
Reason: Acquired by Merck
Source: https://www.merck.com/news/merck-completes-acquisition-of-acceleron-pharma-inc/
Reason: Acquired by Merck
Source: https://www.merck.com/news/merck-completes-acquisition-of-acceleron-pharma-inc/
Acceleron Pharma
XLRN
HK$1,403
Share price
0.00%
Change (1 day)
15,123.75%
Change (1 year)
Categories
Market capitalization of Acceleron Pharma (XLRN)
Last known market cap: HK$85.80 Billion
As of July 2025 Acceleron Pharma has a market cap of HK$85.80 Billion. This makes Acceleron Pharma the world's 1750th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Acceleron Pharma from 2013 to 2022
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2022 | HK$85.41 B | 0.2% |
| 2021 | HK$85.23 B | 42.64% |
| 2020 | HK$59.75 B | 172.42% |
| 2019 | HK$21.93 B | 39.04% |
| 2018 | HK$15.77 B | 5.18% |
| 2017 | HK$14.99 B | 100.79% |
| 2016 | HK$7.46 B | -40.67% |
| 2015 | HK$12.58 B | 28.46% |
| 2014 | HK$9.80 B | 12.59% |
| 2013 | HK$8.70 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | HK$1.271 T | 1,381.99% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | HK$473.40 B | 451.73% | 🇺🇸 USA |
 Johnson & Johnson JNJ | HK$3.142 T | 3,561.99% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | HK$0.16 B | -99.81% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | HK$1.15 B | -98.65% | 🇺🇸 USA |
 bluebird bio
BLUE | HK$0.38 B | -99.55% | 🇺🇸 USA |
 Pfizer PFE | HK$1.084 T | 1,164.33% | 🇺🇸 USA |